Document is current
Any future updates will be listed below
-
Authors
Wei, Angela https://orcid.org/0000-0001-6847-9423
Border, Richard https://orcid.org/0000-0002-6293-2968
Fu, Boyang https://orcid.org/0000-0002-0082-8735
Cullina, Sinéad
Brandes, Nadav https://orcid.org/0000-0002-0510-2546
Jang, Seon-Kyeong
Sankararaman, Sriram https://orcid.org/0000-0003-1586-9641
Kenny, Eimear E.
Udler, Miriam S. https://orcid.org/0000-0003-3824-9162
Ntranos, Vasilis https://orcid.org/0000-0002-2477-0670
Zaitlen, Noah
Arboleda, Valerie A. https://orcid.org/0000-0002-9687-9122
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01HG011345, F31HG013462)
- License Information
-
More Information
Article History
Received: 15 May 2024
Accepted: 20 May 2025
First Online: 5 June 2025
Competing interests
: E.E.K. has received personal fees from Regeneron Pharmaceuticals, 23andMe, Allelica and Illumina; has received research funding from Allelica; and serves on the advisory boards for Encompass Biosciences, Overtone and Galatea Bio. All other authors declare no competing interests.
